• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

3-氨基苯并硼唑类化合物的合成及其结构对其活性的影响。

Synthesis and Influence of 3-Amino Benzoxaboroles Structure on Their Activity against .

机构信息

Faculty of Chemistry, University of Opole, Oleska 48, 45-052 Opole, Poland.

Faculty of Chemistry, Warsaw University of Technology, Noakowskiego 3, 00-664 Warsaw, Poland.

出版信息

Molecules. 2020 Dec 18;25(24):5999. doi: 10.3390/molecules25245999.

DOI:10.3390/molecules25245999
PMID:33352986
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7766895/
Abstract

Benzoxaboroles emerged recently as molecules of high medicinal potential with Kerydin (Tavaborole) and Eucrisa (Crisaborole) currently in clinical practice as antifungal and anti-inflammatory drugs, respectively. Over a dozen of 3-amino benzoxaboroles, including Tavaborole's derivatives, have been synthetized and characterized in terms of their activity against as a model pathogenic fungus. The studied compounds broaden considerably the structural diversity of reported benzoxaboroles, enabling determination of the influence of the introduction of a heterocyclic amine, a fluorine substituent as well as the formyl group on antifungal activity of those compounds. The determined zones of the growth inhibition of examined microorganism indicate high diffusion of majority of the studied compounds within the applied media as well as their reasonable activity. The Minimum Inhibitory Concentration (MIC) values show that the introduction of an amine substituent in position "3" of the benzoxaborole heterocyclic ring results in a considerable drop in activity in comparison with Tavaborole (AN2690) as well as unsubstituted benzoxaborole (AN2679). In all studied cases the presence of a fluorine substituent at position to the boron atom results in lower MIC values (higher activity). Interestingly, introduction of a fluorine substituent in the more distant piperazine phenyl ring does not influence MIC values. As determined by X-ray studies, introduction of a formyl group in proximity of the boron atom results in a considerable change of the boronic group geometry. The presence of a formyl group next to the benzoxaborole unit is also detrimental for activity against .

摘要

苯并恶唑硼烷最近作为具有高药用潜力的分子出现,其中 Kerydin(Tavaborole)和 Eucrisa(Crisaborole)分别作为抗真菌和抗炎药物在临床上使用。已经合成了超过十几种 3-氨基苯并恶唑硼烷,包括 Tavaborole 的衍生物,并对其作为模型致病真菌的活性进行了表征。研究的化合物大大拓宽了报道的苯并恶唑硼烷的结构多样性,使我们能够确定引入杂环胺、氟取代基以及甲酰基对这些化合物抗真菌活性的影响。所测定的微生物生长抑制区域表明,大多数研究化合物在应用介质中有很高的扩散性和合理的活性。最小抑菌浓度 (MIC) 值表明,与 Tavaborole (AN2690) 和未取代的苯并恶唑硼烷 (AN2679) 相比,在苯并恶唑硼烷杂环的 3 位引入胺取代基会导致活性显著下降。在所有研究的情况下,硼原子邻位的氟取代基的存在会导致 MIC 值降低(活性更高)。有趣的是,在更远的哌嗪苯环中引入氟取代基不会影响 MIC 值。通过 X 射线研究确定,在硼原子附近引入甲酰基会导致硼酸基团几何形状发生很大变化。在苯并恶唑硼烷单元附近存在甲酰基也不利于对 的活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0a6/7766895/67a07afa97af/molecules-25-05999-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0a6/7766895/00d5c8d6ed8b/molecules-25-05999-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0a6/7766895/bb7f946c92c4/molecules-25-05999-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0a6/7766895/8515085a6643/molecules-25-05999-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0a6/7766895/fe236eea62ae/molecules-25-05999-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0a6/7766895/c3a0ed6dbdab/molecules-25-05999-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0a6/7766895/67a07afa97af/molecules-25-05999-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0a6/7766895/00d5c8d6ed8b/molecules-25-05999-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0a6/7766895/bb7f946c92c4/molecules-25-05999-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0a6/7766895/8515085a6643/molecules-25-05999-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0a6/7766895/fe236eea62ae/molecules-25-05999-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0a6/7766895/c3a0ed6dbdab/molecules-25-05999-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0a6/7766895/67a07afa97af/molecules-25-05999-g005.jpg

相似文献

1
Synthesis and Influence of 3-Amino Benzoxaboroles Structure on Their Activity against .3-氨基苯并硼唑类化合物的合成及其结构对其活性的影响。
Molecules. 2020 Dec 18;25(24):5999. doi: 10.3390/molecules25245999.
2
5-Trifluoromethyl-2-formylphenylboronic Acid.5-三氟甲基-2-醛基苯硼酸。
Molecules. 2020 Feb 12;25(4):799. doi: 10.3390/molecules25040799.
3
Synthesis, structure, properties and antimicrobial activity of para trifluoromethyl phenylboronic derivatives.对 4-三氟甲基苯硼酸衍生物的合成、结构、性质和抗菌活性的研究。
Bioorg Chem. 2022 Feb;119:105560. doi: 10.1016/j.bioorg.2021.105560. Epub 2021 Dec 13.
4
Mechanochemical synthesis of antifungal bis(benzoxaboroles).抗真菌双(苯并氧杂硼杂环戊烷)的机械化学合成
RSC Adv. 2020 Oct 7;10(61):37187-37193. doi: 10.1039/d0ra07767d.
5
Synthesis of Sordaricin analogues as potent antifungal agents against Candida albicans.作为抗白色念珠菌强效抗真菌剂的索德菌素类似物的合成。
Bioorg Med Chem Lett. 2002 Mar 11;12(5):803-6. doi: 10.1016/s0960-894x(02)00020-3.
6
Efficacy of Novel Schiff base Derivatives as Antifungal Compounds in Combination with Approved Drugs Against Candida Albicans.新型席夫碱衍生物与已批准药物联合治疗白念珠菌的抗真菌活性。
Med Chem. 2019;15(6):648-658. doi: 10.2174/1573406415666181203115957.
7
Crystal structures of the human and fungal cytosolic Leucyl-tRNA synthetase editing domains: A structural basis for the rational design of antifungal benzoxaboroles.人类和真菌胞质亮氨酰 - tRNA合成酶编辑结构域的晶体结构:抗真菌苯并硼唑合理设计的结构基础。
J Mol Biol. 2009 Jul 10;390(2):196-207. doi: 10.1016/j.jmb.2009.04.073. Epub 2009 May 6.
8
The synthesis and synergistic antifungal effects of chalcones against drug resistant Candida albicans.查耳酮对耐药白色念珠菌的合成及协同抗真菌作用
Bioorg Med Chem Lett. 2016 Jul 1;26(13):3098-3102. doi: 10.1016/j.bmcl.2016.05.013. Epub 2016 May 7.
9
Antifungal activity and tautomeric cyclization equilibria of formylphenylboronic acids.甲酰基苯硼酸的抗真菌活性和互变异构平衡。
Bioorg Chem. 2019 Oct;91:103081. doi: 10.1016/j.bioorg.2019.103081. Epub 2019 Jun 25.
10
The influence of fluorine position on the properties of fluorobenzoxaboroles.氟原子位置对氟代苯并硼恶唑性质的影响。
Bioorg Chem. 2015 Jun;60:130-5. doi: 10.1016/j.bioorg.2015.05.004. Epub 2015 May 14.

引用本文的文献

1
Formation and Structural Characterization of Benzoxa- and Thienoxaphosphaborinines.苯并氧杂磷硼杂萘和噻吩并氧杂磷硼杂萘的形成与结构表征
J Org Chem. 2025 Jun 13;90(23):7688-7699. doi: 10.1021/acs.joc.5c00501. Epub 2025 May 21.
2
Merging Electron Deficient Boronic Centers with Electron-Withdrawing Fluorine Substituents Results in Unique Properties of Fluorinated Phenylboronic Compounds.将缺电子的硼中心与吸电子的氟取代基结合,得到具有独特性质的氟化苯基硼酸化合物。
Molecules. 2022 May 26;27(11):3427. doi: 10.3390/molecules27113427.

本文引用的文献

1
Mechanochemical synthesis of antifungal bis(benzoxaboroles).抗真菌双(苯并氧杂硼杂环戊烷)的机械化学合成
RSC Adv. 2020 Oct 7;10(61):37187-37193. doi: 10.1039/d0ra07767d.
2
5-Trifluoromethyl-2-formylphenylboronic Acid.5-三氟甲基-2-醛基苯硼酸。
Molecules. 2020 Feb 12;25(4):799. doi: 10.3390/molecules25040799.
3
Antifungal activity and tautomeric cyclization equilibria of formylphenylboronic acids.甲酰基苯硼酸的抗真菌活性和互变异构平衡。
Bioorg Chem. 2019 Oct;91:103081. doi: 10.1016/j.bioorg.2019.103081. Epub 2019 Jun 25.
4
Boron in drug design: Recent advances in the development of new therapeutic agents.硼在药物设计中的应用:新型治疗剂开发的最新进展。
Eur J Med Chem. 2019 Oct 1;179:791-804. doi: 10.1016/j.ejmech.2019.06.092. Epub 2019 Jul 3.
5
Antifungal Drug Use for Onychomycosis.抗真菌药物治疗甲真菌病。
Am J Ther. 2019 May/Jun;26(3):e388-e396. doi: 10.1097/MJT.0000000000000696.
6
Overview of Recent Strategic Advances in Medicinal Chemistry.近期药物化学战略进展概述。
J Med Chem. 2019 Nov 14;62(21):9375-9414. doi: 10.1021/acs.jmedchem.9b00359. Epub 2019 May 28.
7
Low Antifungal Activity of Tavaborole against Yeasts and Molds from Onychomycosis.他扎罗汀对甲真菌病中酵母菌和霉菌的抗真菌活性较低。
Antimicrob Agents Chemother. 2018 Nov 26;62(12). doi: 10.1128/AAC.01632-18. Print 2018 Dec.
8
Onychomycosis: Treatment and prevention of recurrence.甲真菌病:治疗和预防复发。
J Am Acad Dermatol. 2019 Apr;80(4):853-867. doi: 10.1016/j.jaad.2018.05.1260. Epub 2018 Jun 28.
9
Emerging New Targets for the Treatment of Resistant Fungal Infections.新兴的抗真菌药物治疗靶点。
J Med Chem. 2018 Jul 12;61(13):5484-5511. doi: 10.1021/acs.jmedchem.7b01413. Epub 2018 Jan 16.
10
Human Onychopharmacokinetic and Pharmacodynamic Analyses of ME1111, a New Topical Agent for Onychomycosis.人指甲药代动力学和药效学分析 ME1111,一种治疗甲真菌病的新型局部药物。
Antimicrob Agents Chemother. 2017 Dec 21;62(1). doi: 10.1128/AAC.00779-17. Print 2018 Jan.